Full article: Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model
Population Pharmacokinetics and Pharmacodynamics of Ofloxacin in South African Patients with Multidrug-Resistant Tuberculosis | Antimicrobial Agents and Chemotherapy
Biased computation of probability of target attainment for antimicrobial drugs
Population pharmacokinetics of enrofloxacin and florfenicol in the giant danio (Devario aequipinnatus) following oral administration of both antibiotics and bath administration of enrofloxacin - ScienceDirect
Erin McCreary on X: "@jpogue1 starts overview of polymyxins international consensus guideline with discussion on target to achieve 1 log kill. In murine thigh infection model, free AUC/MIC target ~12, total target ~
Pharmacokinetic and pharmacodynamic profiling of minocycline for injection following a single infusion in critically ill adults
Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patients | Scientific Reports
Frontiers | Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move Forward
Evaluating a tylosin dosage regimen for treatment of Staphylococcus delphini infection in mink (Neovison vison): a pharmacokinetic-pharmacodynamic approach | Veterinary Research | Full Text
Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using I
Prolonged Versus Intermittent Infusion of β-Lactam Antibiotics: A Systematic Review and Meta-Regression of Bacterial Killing in Preclinical Infection Models | Clinical Pharmacokinetics
Mechanism-based PKPD-models for Selection of Dosing Regimens for Antibiotics
Antimicrobials | Anesthesia Key
PPT - What is a MIC ? Relationship between a MIC and conventional pharmacodynamic parameters PowerPoint Presentation - ID:688866
Recent Updates on the Role of Pharmacokinetics- pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical
Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move Forward. - Abstract - Europe PMC
fAUC/MIC values of subcutaneous colistin and polymyxin B at 30 mg/kg/8 h | Download Scientific Diagram
Relationship between MIC and fAUC and proportion of patients with... | Download Scientific Diagram
Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move Forward
Antibiotics | Free Full-Text | Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Escherichia coli
Effect of pharmacokinetic/pharmacodynamic ratio on tigecycline clinical response and toxicity in critically ill patients with mu
Breakpoint Breakdown – Lablogatory
Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation | Antimicrobial Agents and Chemotherapy